Poliglusam (also commonly known as chitosan) is a linear polysaccharide composed of randomly distributed β-(1→4)-linked D-glucosamine and N-acetyl-D-glucosamine. Commercial Poliglusam is derived from deacetylation of chitin contained in the shells of various sea crustaceans such as shrimps. Chitosan is easily prepared from the second most plentiful natural polymer on earth, so it is no surprise that it is being researched as a key component of so many different biomaterials. Several benefits of Poliglusam, such as biocompatibility, biodegradability, biorenewability, bioadhesivity, and nontoxicity have made them important natural polymers for pharmaceutical and cosmetic industries. Poliglusam and its derivatives are biocompatible in a wide range of applications, from hydrogels promoting angiogenesis to a bread supplement that ameliorates diabetes. Poliglusam is also used within some wound dressings to stop bleeding. In agriculture, chitosan is typically used as a natural seed treatment and plant growth enhancer, and as an ecologically friendly biopesticide substance that boosts the innate ability of plants to defend themselves against fungal infections. As a rich source of dietary fiber, chitosan is used as a food ingredient or additive.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Chitooligosaccharides attenuate Cu2+-induced cellular oxidative damage and cell apoptosis involving Nrf2 activation. | 2015-05 |
|
| Low molecular weight chitosan accelerates glucagon-like peptide-1 secretion in human intestinal endocrine cells via a p38-dependent pathway. | 2013-05-22 |
|
| Curcumin encapsulated in chitosan nanoparticles: a novel strategy for the treatment of arsenic toxicity. | 2012-07-30 |
|
| Fungal cell wall agents suppress the innate inflammatory cytokine responses of human peripheral blood mononuclear cells challenged with lipopolysaccharide in vitro. | 2011-08 |
|
| Uptake and cytotoxicity of chitosan nanoparticles in human liver cells. | 2010-12-01 |
|
| Effects of PDT with 5-aminolevulinic acid and chitosan on Walker carcinosarcoma. | 2008-09 |
|
| Preparation of chitosan-polyaspartic acid-5-fluorouracil nanoparticles and its anti-carcinoma effect on tumor growth in nude mice. | 2008-06-14 |
|
| Homogeneous chitosan-PLGA composite fibrous scaffolds for tissue regeneration. | 2008-01 |
|
| Effect of chitosan supplementation on antitubercular drugs-induced hepatotoxicity in rats. | 2006-02-15 |
|
| Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models. | 2005-09 |
|
| [Mechanisms of action of transportation of liposomes and chitosan-coated liposomes containing leuprolide across intestine and Caco-2 cell]. | 2005-01 |
|
| [The study of influence of chitosan on clinical, metabolic and immune parameters in patients with cardiovascular diseases]. | 2005 |
|
| Sodium citrate cross-linked chitosan films: optimization as substitute for human/rat/rabbit epidermal sheets. | 2004-12-20 |
|
| Characterization and blood coagulation evaluation of the water-soluble chitooligosaccharides prepared by a facile fractionation method. | 2003-11-11 |
|
| [Regeneration of the axotomised sciatic nerve in dogs using the tubulisation technique with Chitosan biomaterial preloaded with progesterone]. | 2003-07-02 |
|
| Antioxidative effect of chitosan on chronic carbon tetrachloride induced hepatic injury in rats. | 2003-05-01 |
|
| Nerve regeneration in a collagen-chitosan tissue-engineered skin transplanted on nude mice. | 2003-04 |
|
| [Effect of chitosan in complex management of obesity]. | 2002-08 |
|
| Chitosan for mucosal vaccination. | 2001-11-05 |
|
| The effect of chitin and chitosan on the proliferation of human skin fibroblasts and keratinocytes in vitro. | 2001-11 |
|
| The effect of chitosan on stiffness and glycolytic activity of human bladder cells. | 2001-08-22 |
|
| Healing at skin graft donor sites dressed with chitosan. | 2000-10 |
|
| Further biocompatibility testing of silica-chitosan complex membrane in the production of tissue plasminogen activator by epithelial and fibroblast cells. | 1999 |
|
| [Evaluation of the usefulness of dressings made from chitosan and lyophilized human placenta on wound healing]. | 1997 |
|
| Evaluation of effects of chitosan in preventing hemorrhagic cystitis in rats induced by cyclophosphamide. | 1995-04 |
|
| Reconstruction of epidermis on a chitosan cross-linked collagen-GAG lattice: effect of fibroblasts. | 1993-06 |
| Substance Class |
Polymer
Created
by
admin
on
Edited
Tue Apr 01 16:23:42 GMT 2025
by
admin
on
Tue Apr 01 16:23:42 GMT 2025
|
| Record UNII |
F351U03I47
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID801034387
Created by
admin on Tue Apr 01 16:23:42 GMT 2025 , Edited by admin on Tue Apr 01 16:23:42 GMT 2025
|
PRIMARY | |||
|
F351U03I47
Created by
admin on Tue Apr 01 16:23:42 GMT 2025 , Edited by admin on Tue Apr 01 16:23:42 GMT 2025
|
PRIMARY | |||
|
300000055991
Created by
admin on Tue Apr 01 16:23:42 GMT 2025 , Edited by admin on Tue Apr 01 16:23:42 GMT 2025
|
PRIMARY | |||
|
70694-72-3
Created by
admin on Tue Apr 01 16:23:42 GMT 2025 , Edited by admin on Tue Apr 01 16:23:42 GMT 2025
|
PRIMARY | |||
|
2368131
Created by
admin on Tue Apr 01 16:23:42 GMT 2025 , Edited by admin on Tue Apr 01 16:23:42 GMT 2025
|
PRIMARY | |||
|
F351U03I47
Created by
admin on Tue Apr 01 16:23:42 GMT 2025 , Edited by admin on Tue Apr 01 16:23:42 GMT 2025
|
PRIMARY | |||
|
SUB11808MIG
Created by
admin on Tue Apr 01 16:23:42 GMT 2025 , Edited by admin on Tue Apr 01 16:23:42 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
|
||
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| SALT FORMATION | CHEMICAL |
|
Hydrochloric Acid | QTT17582CB |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| VISCOSITY | PHYSICAL |
|